Literature DB >> 2778758

Antiphospholipid arterial vasculopathy.

D Alarcón-Segovia1, M H Cardiel, E Reyes.   

Abstract

We describe 3 relatively young patients who developed arterial occlusions in a limb requiring amputation. All 3 had antiphospholipid antibodies (APLA). In one, these appeared as part of the clinical and serologic spectrum of systemic lupus erythematosus and in the other 2 as a component of a primary antiphospholipid syndrome. Their arterial angiograms showed gradual narrowing of the arterial lumen and the histopathologic study showed striking intimal and medial proliferation as well as some increase in thickness of the adventitia. There was little evidence of thrombosis but in the 2 patients who were amputated early there was mononuclear cell infiltrate of the large arteries and in all 3 there was also leukocytoclastic vasculitis in the skin and/or muscle. We believe this represents a new form of vasculopathy, probably related to the presence of APLA, possibly triggered by the occurrence of vasculitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778758

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

Review 1.  Antiphospholipid antibodies and the endothelium.

Authors:  B J Hunt; M A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

2.  Histological appearance of the intra-osseous vessels of the femoral head in aseptic osteonecrosis of the hip, with or without antiphospholipid antibodies.

Authors:  M Laroche; I Ludot; M Thiechart; G Viguier; C Dromer; B Mazières
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

3.  Histopathological findings in a case of systemic lupus erythematosus-associated anti-phospholipid syndrome.

Authors:  P L Meroni; R Rivolta; P Ghidoni
Journal:  Clin Rheumatol       Date:  1991-06       Impact factor: 2.980

Review 4.  Treatment of the antiphospholipid syndrome.

Authors:  J C Piette; M Karmochkine; T Papo; L T Du; C Francès; B Wechsler
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

5.  Polyarteritis nodosa and the antiphospholipid syndrome.

Authors:  R Schoonjans; B Van Vlem; S Weyers; F De Keyser; M Praet; J Versieck; A Elewaut
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

6.  Buerger's disease and antiphospholipid syndrome.

Authors:  X Puéchal; C Job-Deslandre; C J Menkès; J N Fiessinger
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

Review 7.  Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  Paul R J Ames; Annamaria Margarita; Jose Delgado Alves
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 8.  Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature.

Authors:  J M Durand; P Lefevre; G Kaplanski; P Casanova; J Soubeyrand
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

9.  Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology.

Authors:  E Toussirot; D Figarella-Branger; P Disdier; J R Harle; P J Weiller
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

10.  Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis.

Authors:  C L Yu; K H Sun; C Y Tsai; S R Wang
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.